KIT and acute myeloid leukemia: The t(8;21) AML patients with high miR-130 expression have an inclination to have KIT mutation (Figure 2(F)), and most of them received allogenic stem cell transplantation after standard induction and two cycles of consolidation chemotherapy consisting of high-dose cytarabine.